{
    "id": "dbpedia_2897_3",
    "rank": 11,
    "data": {
        "url": "https://www.bfarm.de/EN/Home/_node.html",
        "read_more_link": "",
        "language": "en",
        "title": "Homepage",
        "top_image": "",
        "meta_img": "",
        "images": [
            "https://www.bfarm.de/SiteGlobals/Frontend/Images/logo_en.svg?__blob=normal&v=1",
            "https://www.bfarm.de/SiteGlobals/Frontend/Images/icons/loupe-b.svg?__blob=normal&v=2",
            "https://www.bfarm.de/SiteGlobals/Frontend/Images/icons/menu-open.svg?__blob=normal&v=2",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Themenbuehne/TB_rote-hand-brief.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Themenbuehne/TB_EU-Flagge2.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Themenbuehne/TB_EU_flagge.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/EN/Photos/Code-systems/TB-iris-logo.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Themenbuehne/TB_rote-hand-brief.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Themenbuehne/TB_Blog.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Themenbuehne/TB_antibiotikaresistenzen.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Themenbuehne/TB_Impulsbericht-2023.jpg?__blob=normal",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Medizinprodukte/diga_verzeichnis_mobil.jpg?__blob=wide",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Arzneimittel/antibiotikaresistenzen.jpg?__blob=wide",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Allgemein/europaflagge.jpg?__blob=wide",
            "https://www.bfarm.de/SharedDocs/Bilder/DE/Fotos/Das-BfArM/Forschung/forschung_reagenzglas.jpg?__blob=wide"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            "Homepage"
        ],
        "tags": null,
        "authors": [],
        "publish_date": null,
        "summary": "",
        "meta_description": "The Federal Institute for Drugs and Medical Devices (Bundesinstitut für Arzneimittel und Medizinprodukte, BfArM) is an independent federal higher authority within the portfolio of the Federal Ministry of Health.",
        "meta_lang": "en",
        "meta_favicon": "/SiteGlobals/Frontend/Images/favicon.ico?__blob=normal&v=3",
        "meta_site_name": "",
        "canonical_link": "https://www.bfarm.de/EN/Home/_node.html",
        "text": "DiGA and DiPA\n\nDigital applications are an important element in the digital modernisation of health care and nursing in Germany. They are part of the future eHealth infrastructure and will interact closely with other digital elements such as the electronic health record (ePA).\n\nRead more\n\nAntibiotic resistances\n\nAntibiotics are indispensable for the treatment of infectious diseases caused by bacteria. The fight against antibiotic resistance is therefore enormously important in order to ensure that patients will be optimally treated with effective drugs in the future. BfArM contributes its expertise to a number of projects and initiatives to protect \"older\" anti­biotics and to drive forward the development and research of new antibiotics.\n\nRead more\n\nEurope and International\n\nThe BfArM is the largest drug approval authority in Europe. Experts contribute their knowledge to the scientific committees of the European Medicines Agency (EMA), among others. Throughout the EU and internationally, BfArM makes a significant contribution to the supply of safe and effective medicines.\n\nRead more\n\nResearch\n\nResearch at the BfArM concentrates on important and contemporary research focal points with regard to the marketing authorisation of medicinal products and improving the safety as well as concerning the recording and assessment of risks in connection with medical devices.\n\nRead more"
    }
}